Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Decision Diagnostics Corp DECN
(Total Views: 366)
Posted On: 06/08/2017 2:07:39 PM
Post# of 11803
Posted By: plutonium
Re: weaver_525 #741
For what its worth, if I were to forecast the GenPrecis product from DECN, and there will be multiple bidders for the product if DECN decides to partner with one of the giants, but I would forecast 6% market share in the U.S. after 3 full years post FDA pre-market.

The diabetes arena has seen enough of the cheap Chinese products, and enough of the feature rich, over-priced meter entries from the Big 4, but the diabetes world has not seen (yet) an affordable feature rich meter along with a test strip that is a +/- 10% 97% of the time. That would make GenPrecis 33% better than everyone else.

Just my opinion. But GenPrecis could be a $15-$25 million cash sale product if it is licensed to a legit partner (hopefully my company who desperately needs a new and better product). Even more if GenPrecis is sold by its creators.

However, like I have said, technical innovation doesn't matter. Profits don't really matter. Having a once in a generation product doesn't matter. The only thing that matters is share price and message board posters have made that soooo clear.













(4)
(1)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site